| Literature DB >> 33925407 |
Marco Del Giudice1,2, Serena Peirone1,3, Sarah Perrone1,4, Francesca Priante1,4, Fabiola Varese1,5, Elisa Tirtei6, Franca Fagioli6,7, Matteo Cereda1,2.
Abstract
Artificial intelligence, or the discipline of developing computational algorithms able to perform tasks that requires human intelligence, offers the opportunity to improve our idea and delivery of precision medicine. Here, we provide an overview of artificial intelligence approaches for the analysis of large-scale RNA-sequencing datasets in cancer. We present the major solutions to disentangle inter- and intra-tumor heterogeneity of transcriptome profiles for an effective improvement of patient management. We outline the contributions of learning algorithms to the needs of cancer genomics, from identifying rare cancer subtypes to personalizing therapeutic treatments.Entities:
Keywords: RNA sequencing; artificial intelligence; cancer heterogeneity
Year: 2021 PMID: 33925407 DOI: 10.3390/ijms22094563
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923